Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation

Although the oral administration of Bifidobacterium longum (B. longum) relieves the signs of irritable bowel syndrome (IBS) in clinical settings, the mechanisms underlying its effects are unclear. In this study, we evaluated the precise effects of B. longum on IBS via regulation of Paneth cell funct...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gut Microbes
Main Authors: Zhou, Chunhua, Fang, Xue, Xu, Jiajia, Gao, Jun, Zhang, Ling, Zhao, Jiulong, Meng, Yuting, Zhou, Wei, Han, Xu, Bai, Yu, Li, Zhaoshen, Zou, Duowu
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524277/
https://ncbi.nlm.nih.gov/pubmed/32584650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19490976.2020.1782156
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares